drugset / Trial / NCT01225835
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is aimed to demonstrate that highly purified Menotrophin produces significant lower progesterone serum levels during the follicular phase in comparison to Follitropin alpha in the treatment of subfertile females undergoing an in vitro fertilisation (IVF) and to investigate if the progesterone serum levels might be a useful predictor for the success rate of the ongoing pregnancy rates
Timeline
- Start
- 2010-10
- Primary completion
- 2013-01
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Follitrophin alpha | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Comparator | Follitrophin alpha | Protein / enzyme biologic | 300 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 300 iu | Subcutaneous |
| Background | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |
| Background | Choriongonadotropin | Unknown | 10000 iu | — |
| Background | Progesterone | Other / unclassified | 90 mg | Other |